LEONHARDT VENTURES NEWS
Two innovation leaders team up to launch clinical study aimed to prove improvement in wound healing especially in patients facing limb loss
“This combination technology platform has potential to preserve thousands of limbs, enhance millions of lives and dramatically reduce long term care cost burdens." stated Dr. Dennis Pena, Investigator Mission Viejo, CA (Newsworthy.ai) Wednesday Mar 26, 2025 @ 7:00 AM...
Lionheart Health, Inc. to Present at Upcoming LSI US ’25 Emerging Medtech Summit
IRVINE, Calif.- (Newsworthy AI) - Lionheart Health, Inc., a privately held company that is an innovation leader in healthspan longevity extension technologies and medical aesthetics, today announced that Howard Leonhardt, Executive Chairman and CEO, will present at...
Lionheart Health Announces the Filing of Provisional Patent Application For Bioelectric Enhanced Super PRF and Klotho Expressing Stem Cells Combination
February 24th, 2025 Irvine, California - Lionheart Health, Inc. working with Leonhardt Ventures LLC, an innovation leader focused on developing unique solutions to aging, announces the filing of a new provisional patent application on a bioelectric enhanced PRF and...
Lionheart Longevity & Wellness Announces Healthspan and Beauty Retreats in Partnership with Local Hotels
Mission Viejo, CA (March 9th, 2025) – Lionheart Longevity & Wellness today announced a series of exclusive healthspan and beauty retreats in partnership with premier hotels across the United States and Mexico, beginning in July 2025. These immersive experiences...
Leonhardt Ventures LLC and Licensee Lionheart Health, Inc. Granted U.S. Patent for Bioelectric Stem Cell Homing, Proliferation and Differentiation Control
Dec. 20th, 2024 - Irvine, California --(AINewsworthy)-- Leonhardt Ventures LLC is pleased to announce the issuance of U.S. Leonhardt et. al. Patent 12,109,410 with 15 claims entitled “Bioelectric Stimulator”, a significant advancement in the field of regenerative...
Executive Chairman’s Best guess estimate June 2023 on portfolio assets closest to exit
Executive Chairman's Best guess estimate June 2023 on portfolio assets closest to exit Note - ALL bioelectric products are based on same exact core stimulator with only slightly different signal sequence protocols. Nearly all use our stem cell homing and circulation...
2023 Annual Shareholder Meeting.
Dear Shareholders, Ahead of our 2023 Annual Shareholder Meeting... 1. 2022 Year End Financials https://lventuresnew.wpenginepowered.com/wp-content/uploads/2023/01/12-Dec-2022-Cal-XStarsBusinessAcceleratorInc.Financials-V1-1-17-23.pdf. 2. See 2023 budget attached and...
Episode 138: Howard Leonhardt – The Future of Longevity & Wellness is Here!
The First Lady of Nutrition welcomes Howard Leonhardt, the extraordinary founder of Leonhardt Ventures LLC and Lionheart Health, Inc. Leonhardt Ventures is the world’s first Innovation Accelerator focused on the convergence of bioelectrics & biologics for organ...
1Q 2023 Update Letter to Shareholders for accelerator and portfolio
Published: March 9th, 2023 Mission Viejo and Irvine, Calif., March 9th, 2023 (PRDistribution) -- Dear Stakeholders, Nearly our entire portfolio of startups made great strides in progress in 2022 and are off to great start in early 2023. Here is a link to the...
BodStim Suits Up To Revolutionize Fitness And Shows Significant Promise For Enhancing Longevity
Bioelectrics is poised to be the next frontier of medical technology, and LionHeart Health is developing therapies on several important fronts. by Susan Belknapp, Senior Writer, California Business Journal Klotho. You may not have heard of it, but this protein is...